TrialDiabetes, obesity & metabolism2009

Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients.

T Heise et al.PubMed ↗Publisher ↗

No numbers read from the abstract.